International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abe, 2017, Discovery of VU6005649, a CNS penetrant mGlu7/8 receptor PAM derived from a series of pyrazolo[1,5-a]pyrimidines, ACS Med Chem Lett, 8, 1110, 10.1021/acsmedchemlett.7b00317
Abe, 1992, Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction, J Biol Chem, 267, 13361, 10.1016/S0021-9258(18)42219-3
Acher F Battaglia G Bräuner-Osborne H Conn PJ Duvoisin R Ferraguti F Flor PJ Goudet C Gregory KJ Hampson D (2019) Metabotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE 4 Available from: 10.2218/gtopdb/F40/2019.4.
Acosta-Ruiz, 2020, Branched photoswitchable tethered ligands enable ultra-efficient optical control and detection of G protein-coupled receptors in vivo, Neuron, 105, 446, 10.1016/j.neuron.2019.10.036
Adams, 2014, Pomaglumetad methionil (LY2140023 monohydrate) and aripiprazole in patients with schizophrenia: a phase 3, multicenter, double-blind comparison, Schizophr Res Treatment, 2014, 758212, 10.1155/2014/758212
Ahnaou, 2016, Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: sleep EEG correlates in rodents and healthy men, Neuropharmacology, 103, 290, 10.1016/j.neuropharm.2015.11.031
Ahnaou, 2015, mGlu2 receptor agonism, but not positive allosteric modulation, elicits rapid tolerance towards their primary efficacy on sleep measures in rats, PLoS One, 10, e0144017, 10.1371/journal.pone.0144017
Ahnaou, 2016, Off-target potential of AMN082 on sleep EEG and related physiological variables: evidence from mGluR7 (-/-) mice, Behav Brain Res, 311, 287, 10.1016/j.bbr.2016.05.035
Annes, 2015, Relative contributions of presystemic and systemic peptidases to oral exposure of a novel metabotropic glutamate 2/3 receptor agonist (LY404039) after oral administration of prodrug pomaglumetad methionil (LY2140023), J Pharm Sci, 104, 207, 10.1002/jps.24226
Aubrey, 2017, Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses, J Physiol, 595, 165, 10.1113/JP272292
Augier, 2016, The mGluR2 positive allosteric modulator, AZD8529, and cue-induced relapse to alcohol seeking in rats, Neuropsychopharmacology, 41, 2932, 10.1038/npp.2016.107
Bahi, 2012, Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats, Addict Biol, 17, 235, 10.1111/j.1369-1600.2010.00310.x
Bailey, 2016, Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study, J Neurodev Disord, 8, 1, 10.1186/s11689-015-9134-5
Battaglia, 2018, Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications, Curr Opin Pharmacol, 38, 65, 10.1016/j.coph.2018.02.007
Bellozi, 2019, A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer’s disease, Neuropharmacology, 160, 107785, 10.1016/j.neuropharm.2019.107785
Benvenga, 2018, Metabotropic glutamate2 receptors play a key role in modulating head twitches induced by a serotonergic hallucinogen in mice, Front Pharmacol, 9, 208, 10.3389/fphar.2018.00208
Berizzi, 2020, Strategies and considerations of G-protein-coupled receptor photopharmacology, Adv Pharmacol, 88, 143, 10.1016/bs.apha.2019.12.001
Boccella, 2020, The modulation of pain by metabotropic glutamate receptors 7 and 8 in the dorsal striatum, Curr Neuropharmacol, 18, 34, 10.2174/1570159X17666190618121859
Bond, 2000, Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo, J Pharmacol Exp Ther, 294, 800
Bradley, 2011, Defining protein kinase/phosphatase isoenzymic regulation of mGlu5 receptor-stimulated phospholipase C and Ca2+ responses in astrocytes, Br J Pharmacol, 164, 755, 10.1111/j.1476-5381.2011.01421.x
Broichhagen, 2015, Orthogonal optical control of a G protein-coupled receptor with a SNAP-tethered photochromic ligand, ACS Cent Sci, 1, 383, 10.1021/acscentsci.5b00260
Car, 2006, Antidepressant-like effects of baclofen and LY367385 in the forced swim test in rats, Pharmacol Rep, 58, 758
Cartmell, 1999, The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats, J Pharmacol Exp Ther, 291, 161
Chaki, 2018, mGlu receptors as potential targets for novel antidepressants, Curr Opin Pharmacol, 38, 24, 10.1016/j.coph.2018.02.001
Charvin, 2018, mGlu4 allosteric modulation for treating Parkinson’s disease, Neuropharmacology, 135, 308, 10.1016/j.neuropharm.2018.03.027
Charvin, 2018, An mGlu4-positive allosteric modulator alleviates Parkinsonism in primates, Mov Disord, 33, 1619, 10.1002/mds.27462
Charvin, 2018, Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs, Nat Rev Drug Discov, 17, 804, 10.1038/nrd.2018.136
Charvin, 2017, Discovery, structure-activity relationship, and antiparkinsonian effect of a potent and brain-penetrant chemical series of positive allosteric modulators of metabotropic glutamate receptor 4, J Med Chem, 60, 8515, 10.1021/acs.jmedchem.7b00991
Chen, 2020, Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5, Basic Clin Pharmacol Toxicol, 126, 104, 10.1111/bcpt.13239
Cho, 2014, A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors, ACS Chem Neurosci, 5, 597, 10.1021/cn5000343
Cho, 2014, Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics, ACS Chem Biol, 9, 2334, 10.1021/cb500560h
Chojnacka-Wójcik, 1996, Anxiolytic-like effects of metabotropic glutamate antagonist (RS)-alpha-methylserine-O-phosphate in rats, Pol J Pharmacol, 48, 507
Cid, 2014, Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptor, J Med Chem, 57, 6495, 10.1021/jm500496m
Cieślik, 2018, Negative allosteric modulators of mGlu7 receptor as putative antipsychotic drugs, Front Mol Neurosci, 11, 316, 10.3389/fnmol.2018.00316
Cleva, 2012, Differential modulation of thresholds for intracranial self-stimulation by mGlu5 positive and negative allosteric modulators: implications for effects on drug self-administration, Front Pharmacol, 2, 93, 10.3389/fphar.2011.00093
Commare, 2015, Determination of the absolute configuration of phosphinic analogues of glutamate, Org Biomol Chem, 13, 1106, 10.1039/C4OB01960A
Conti, 2002, Synthesis and pharmacology of 3-hydroxy-delta2-isoxazoline-cyclopentane analogues of glutamic acid, Farmaco, 57, 889, 10.1016/S0014-827X(02)01307-1
Copani, 1995, Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide, Mol Pharmacol, 47, 890
Crawford, 1997, Activation of Ca2+-dependent currents in dorsal root ganglion neurons by metabotropic glutamate receptors and cyclic ADP-ribose precursors, J Neurophysiol, 77, 2573, 10.1152/jn.1997.77.5.2573
Cross, 2018, Metabotropic glutamate receptors 2 and 3 as targets for treating nicotine addiction, Biol Psychiatry, 83, 947, 10.1016/j.biopsych.2017.11.021
Crupi, 2019, Role of metabotropic glutamate receptors in neurological disorders, Front Mol Neurosci, 12, 20, 10.3389/fnmol.2019.00020
Cuomo, 2009, Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson’s disease treatment, J Neurochem, 109, 1096, 10.1111/j.1471-4159.2009.06036.x
Dalton, 2017, Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand, Sci Rep, 7, 4944, 10.1038/s41598-017-05095-5
D’Amore, 2016, The anti-absence effect of mGlu5 receptor amplification with VU0360172 is maintained during and after antiepileptogenesis, Pharmacol Biochem Behav, 146–147, 50, 10.1016/j.pbb.2016.05.004
D’Amore, 2014, Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats, Neuropharmacology, 85, 91, 10.1016/j.neuropharm.2014.05.005
D’Amore, 2013, Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats, Neuropharmacology, 66, 330, 10.1016/j.neuropharm.2012.05.044
Dekundy, 2011, Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia, J Neural Transm (Vienna), 118, 1703, 10.1007/s00702-010-0526-0
Di Menna, 2018, Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system, Neuropharmacology, 128, 301, 10.1016/j.neuropharm.2017.10.026
DiRaddo, 2013, Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor, Gene, 519, 367, 10.1016/j.gene.2013.02.009
Domenici, 2004, Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum, J Neurochem, 90, 1276, 10.1111/j.1471-4159.2004.02607.x
Domin, 2014, Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo, Neurotox Res, 26, 99, 10.1007/s12640-013-9455-7
Domin, 2016, Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: in vitro and in vivo studies, Neuropharmacology, 102, 276, 10.1016/j.neuropharm.2015.11.025
Domin, 2018, Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertension, Prog Neuropsychopharmacol Biol Psychiatry, 84, 93, 10.1016/j.pnpbp.2018.02.006
Donthamsetti, 2019, Genetically targeted optical control of an endogenous G protein-coupled receptor, J Am Chem Soc, 141, 11522, 10.1021/jacs.9b02895
Doornbos, 2016, Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222, Br J Pharmacol, 173, 588, 10.1111/bph.13390
Doornbos, 2017, Discovery and kinetic profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: positive allosteric modulators of the metabotropic glutamate receptor 2, J Med Chem, 60, 6704, 10.1021/acs.jmedchem.7b00669
Doornbos, 2019, Covalent allosteric probe for the metabotropic glutamate receptor 2: design, synthesis, and pharmacological characterization, J Med Chem, 62, 223, 10.1021/acs.jmedchem.8b00051
Doria, 2018, The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington’s disease, J Neurochem, 147, 222, 10.1111/jnc.14555
Dravolina, 2017, mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?, Psychopharmacology (Berl), 234, 1333, 10.1007/s00213-017-4581-1
Durand, 2011, Reduced cAMP, Akt activation and p65-c-Rel dimerization: mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes, PLoS One, 6, e22235, 10.1371/journal.pone.0022235
Elia, 2018, Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling, Nat Commun, 9, 4, 10.1038/s41467-017-02244-2
Eng, 2016, Transduction of group I mGluR-mediated synaptic plasticity by β-arrestin2 signalling, Nat Commun, 7, 13571, 10.1038/ncomms13571
Engers, 2016, Discovery, synthesis, and preclinical characterization of N-(3-chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu4), ACS Chem Neurosci, 7, 1192, 10.1021/acschemneuro.6b00035
Engers, 2010, Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS), Bioorg Med Chem Lett, 20, 5175, 10.1016/j.bmcl.2010.07.007
Engers, 2017, Design and synthesis of N-aryl phenoxyethoxy pyridinones as highly selective and CNS penetrant mGlu3 NAMs, ACS Med Chem Lett, 8, 925, 10.1021/acsmedchemlett.7b00249
Engers, 2015, Discovery of a selective and CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 with antidepressant and anxiolytic activity in rodents, J Med Chem, 58, 7485, 10.1021/acs.jmedchem.5b01005
Farinha, 2015, Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2, Br J Pharmacol, 172, 2383, 10.1111/bph.13065
Fazio, 2017, Cinnabarinic acid and xanthurenic acid: two kynurenine metabolites that interact with metabotropic glutamate receptors, Neuropharmacology, 112, 365, 10.1016/j.neuropharm.2016.06.020
Feenstra, 1998, Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors, J Neurochem, 70, 1104, 10.1046/j.1471-4159.1998.70031104.x
Fell, 2010, Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge, Neuropharmacology, 58, 632, 10.1016/j.neuropharm.2009.11.014
Felsing, 2018, Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction, PLoS One, 13, e0203137, 10.1371/journal.pone.0203137
Felts, 2015, Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as selective negative allosteric modulators of metabotropic glutamate receptor subtype 2, J Med Chem, 58, 9027, 10.1021/acs.jmedchem.5b01371
Ferré, 1999, Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum, Neuropharmacology, 38, 129, 10.1016/S0028-3908(98)00154-3
Fisher, 2018, Metabotropic glutamate receptor 7: a new therapeutic target in neurodevelopmental disorders, Front Mol Neurosci, 11, 387, 10.3389/fnmol.2018.00387
Font, 2017, Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator [published correction appears in eLife (2018) 7:e34752], eLife, 6, e23545, 10.7554/eLife.23545
Fukuda, 1985, Quisqualic acid-induced hippocampal seizures in unanesthetized cats, Neurosci Lett, 59, 53, 10.1016/0304-3940(85)90214-9
Fuzzati-Armentero, 2015, Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson’s disease, J Neurochem, 134, 740, 10.1111/jnc.13162
Gandhi, 2014, 2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice, Front Cell Neurosci, 8, 70, 10.3389/fncel.2014.00070
Garcia-Barrantes, 2015, Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 1: SAR of modifications to the central aryl core, Bioorg Med Chem Lett, 25, 5107, 10.1016/j.bmcl.2015.10.013
Garcia-Barrantes, 2016, Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs, Bioorg Med Chem Lett, 26, 1869, 10.1016/j.bmcl.2016.03.031
Garcia-Barrantes, 2015, Development of novel, CNS penetrant positive allosteric modulators for the metabotropic glutamate receptor subtype 1 (mGlu1), based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide scaffold, that potentiate wild type and mutant mGlu1 receptors found in schizophrenics, J Med Chem, 58, 7959, 10.1021/acs.jmedchem.5b00727
Garcia-Barrantes, 2016, Re-exploration of the mGlu1 PAM Ro 07-11401 scaffold: discovery of analogs with improved CNS penetration despite steep SAR, Bioorg Med Chem Lett, 26, 2289, 10.1016/j.bmcl.2016.03.044
García-Bea, 2017, A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding, J Psychopharmacol, 31, 1519, 10.1177/0269881117715597
Gasparini, 1999, (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo, J Pharmacol Exp Ther, 289, 1678
Gass, 2017, Deficits in the extinction of ethanol-seeking behavior following chronic intermittent ethanol exposure are attenuated with positive allosteric modulation of mGlu5, Neuropharmacology, 113, 198, 10.1016/j.neuropharm.2016.10.005
Gawel, 2018, The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands, Physiol Behav, 185, 112, 10.1016/j.physbeh.2017.12.035
Gelb, 2015, Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells, Biochem Pharmacol, 98, 182, 10.1016/j.bcp.2015.08.091
Gelb, 2015, Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas, Oncogene, 34, 2711, 10.1038/onc.2014.231
Ghoshal, 2017, Role of mGlu5 receptors and inhibitory neurotransmission in M1 dependent muscarinic LTD in the prefrontal cortex: implications in schizophrenia, ACS Chem Neurosci, 8, 2254, 10.1021/acschemneuro.7b00167
Girard, 2019, The mGlu7 receptor provides protective effects against epileptogenesis and epileptic seizures, Neurobiol Dis, 129, 13, 10.1016/j.nbd.2019.04.016
Golubeva, 2016, Metabotropic glutamate receptors in central nervous system diseases, Curr Drug Targets, 17, 538, 10.2174/1389450116666150316224011
Gómez-Santacana, 2017, Illuminating phenylazopyridines to photoswitch metabotropic glutamate receptors: from the flask to the animals, ACS Cent Sci, 3, 81, 10.1021/acscentsci.6b00353
Goudet, 2018, Shedding light on metabotropic glutamate receptors using optogenetics and photopharmacology, Curr Opin Pharmacol, 38, 8, 10.1016/j.coph.2018.01.007
Gregory, 2019, In vitro to in vivo translation of allosteric modulator concentration-effect relationships: implications for drug discovery, ACS Pharmacol Transl Sci, 2, 442, 10.1021/acsptsci.9b00062
Gregory, 2020, Evaluation of operational models of agonism and allosterism at receptors with multiple orthosteric binding sites, Mol Pharmacol, 97, 35, 10.1124/mol.119.118091
Gregory, 2018, Dual action calcium-sensing receptor modulator unmasks novel mode-switching mechanism, ACS Pharmacol Transl Sci, 1, 96, 10.1021/acsptsci.8b00021
Gregory KJ Malosh C Turlington M Morrison R Vinson P Daniels JS Jones C Niswender CM Conn PJ Lindsley CW (2010a) Identification of a high affinity MPEP-site silent allosteric modulator (SAM) for the metabotropic glutamate subtype 5 receptor (mGlu5), Probe Reports from the NIH Molecular Libraries Program, National Center for Biotechnology Information (US), Bethesda, MD.
Gregory, 2010, Overview of receptor allosterism, Curr Protoc Pharmacol, Chapter 1, Unit 1.21
Gregory, 2016, Clickable photoaffinity ligands for metabotropic glutamate receptor 5 based on select acetylenic negative allosteric modulators, ACS Chem Biol, 11, 1870, 10.1021/acschembio.6b00026
Griebel, 2016, The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia, Sci Rep, 6, 35320, 10.1038/srep35320
Gutzeit, 2019, Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor, eLife, 8, e45116, 10.7554/eLife.45116
Haas, 2007, The non-competitive metabotropic glutamate receptor-1 antagonist CPCCOEt inhibits the in vitro growth of human melanoma, Oncol Rep, 17, 1399
Habrian, 2019, Conformational pathway provides unique sensitivity to a synaptic mGluR, Nat Commun, 10, 5572, 10.1038/s41467-019-13407-8
Hajasova, 2018, Role of mGlu7 receptor in morphine rewarding effects is uncovered by a novel orthosteric agonist, Neuropharmacology, 131, 424, 10.1016/j.neuropharm.2018.01.002
Halberstadt, 2019, Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen, Psychopharmacology (Berl), 236, 821, 10.1007/s00213-018-5118-y
Hall, 2013, Application of receptor theory to allosteric modulation of receptors, Prog Mol Biol Transl Sci, 115, 217, 10.1016/B978-0-12-394587-7.00006-3
Hanak, 2019, Positive modulation of mGluR5 attenuates seizures and reduces TNF-α+ macrophages and microglia in the brain in a murine model of virus-induced temporal lobe epilepsy, Exp Neurol, 311, 194, 10.1016/j.expneurol.2018.10.006
Hanna, 2013, Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist, Neuropharmacology, 66, 114, 10.1016/j.neuropharm.2012.02.023
Hathaway, 2015, Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism, Neuropharmacology, 93, 199, 10.1016/j.neuropharm.2015.02.007
Hellyer, 2020, Development of clickable photoaffinity ligands for metabotropic glutamate receptor 2 based on two positive allosteric modulator chemotypes, ACS Chem Neurosci, 11, 1597, 10.1021/acschemneuro.0c00009
Hellyer, 2019, Metabotropic glutamate receptor 5 (mGlu5 )-positive allosteric modulators differentially induce or potentiate desensitization of mGlu5 signaling in recombinant cells and neurons, J Neurochem, 151, 301, 10.1111/jnc.14844
Hellyer, 2020, Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site, Biochem Pharmacol, 177, 114013, 10.1016/j.bcp.2020.114013
Helton, 1998, Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors, J Pharmacol Exp Ther, 284, 651
Henrich-Noack, 1999, (1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia, Eur J Pharmacol, 365, 55, 10.1016/S0014-2999(98)00865-6
Hikichi, 2013, Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats, J Pharmacol Sci, 122, 10, 10.1254/jphs.13036FP
Hinoi, 2000, Direct radiolabeling by [3H]quisqualic acid of group I metabotropic glutamate receptor in rat brain synaptic membranes, Brain Res, 881, 199, 10.1016/S0006-8993(00)02809-2
Hoffmann, 2017, Long-lasting impairment of mGluR5-activated intracellular pathways in the striatum after withdrawal of cocaine self-administration, Int J Neuropsychopharmacol, 20, 72
Hong, 2016, The thalamic mGluR1-PLCβ4 pathway is critical in sleep architecture, Mol Brain, 9, 100, 10.1186/s13041-016-0276-5
Horio, 2013, Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice, Fundam Clin Pharmacol, 27, 483, 10.1111/j.1472-8206.2012.01045.x
Hu, 2019, Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation, Acta Pharmacol Sin, 40, 460, 10.1038/s41401-018-0033-7
Huang, 2018, L-DOPA-induced motor impairment and overexpression of corticostriatal synaptic components are improved by the mGluR5 antagonist MPEP in 6-OHDA-lesioned rats, ASN Neuro, 10, 1759091418811021, 10.1177/1759091418811021
Iderberg, 2015, Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson’s disease and L-DOPA-induced dyskinesia: comparison between a positive allosteric modulator and an orthosteric agonist, Neuropharmacology, 95, 121, 10.1016/j.neuropharm.2015.02.023
Isherwood, 2017, Selective and interactive effects of D2 receptor antagonism and positive allosteric mGluR4 modulation on waiting impulsivity, Neuropharmacology, 123, 249, 10.1016/j.neuropharm.2017.05.006
Itil, 1978, The clinical and quantitative EEG effects and plasma levels of fenobam (McN-3377) in subjects with anxiety: an open rising dose tolerance and efficacy study, Curr Ther Res Clin Exp, 24, 708
Ito, 2009, Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: a potential treatment for psychotic disorders, Bioorg Med Chem Lett, 19, 5310, 10.1016/j.bmcl.2009.07.145
Jacob, 2009, The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning, Neuropharmacology, 57, 97, 10.1016/j.neuropharm.2009.04.011
Jenda, 2015, AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice, Prog Neuropsychopharmacol Biol Psychiatry, 57, 166, 10.1016/j.pnpbp.2014.11.004
Jia, 1998, Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5, Learn Mem, 5, 331, 10.1101/lm.5.4.331
Jin, 2017, An essential role of Fyn in the modulation of metabotropic glutamate receptor 1 in neurons, eNeuro, 4, ENEURO.0096, 10.1523/ENEURO.0096-17.2017
Jin, 2018, The role of extracellular signal-regulated kinases (ERK) in the regulation of mGlu5 receptors in neurons, J Mol Neurosci, 66, 629, 10.1007/s12031-018-1193-0
Jin, 2015, Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII, Brain Res, 1624, 414, 10.1016/j.brainres.2015.07.053
Joffe, 2019, Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress, Neuropharmacology, 144, 19, 10.1016/j.neuropharm.2018.10.013
Jong, 2019, Location and cell-type-specific bias of metabotropic glutamate receptor, mGlu5, negative allosteric modulators, ACS Chem Neurosci, 10, 4558, 10.1021/acschemneuro.9b00415
Justinova, 2015, The novel metabotropic glutamate receptor 2 positive allosteric modulator, AZD8529, decreases nicotine self-sdministration and relapse in squirrel monkeys, Biol Psychiatry, 78, 452, 10.1016/j.biopsych.2015.01.014
Kahl, 2016, Metabotropic glutamate receptors 7 within the nucleus accumbens are involved in relief learning in rats, Curr Neuropharmacol, 14, 405, 10.2174/1570159X13666150425002017
Kawaura, 2016, Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats, Pharmacol Rep, 68, 80, 10.1016/j.pharep.2015.05.027
Kent, 2016, Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression, Prog Neuropsychopharmacol Biol Psychiatry, 67, 66, 10.1016/j.pnpbp.2016.01.009
Kim, 1998, The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats, Neuropharmacology, 37, 189, 10.1016/S0028-3908(98)00015-X
Kłak, 2007, Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats, Amino Acids, 32, 169, 10.1007/s00726-006-0316-z
Kubas, 2013, Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators, Bioorg Med Chem Lett, 23, 6370, 10.1016/j.bmcl.2013.09.059
Kubota, 2014, mGluR1-mediated excitation of cerebellar GABAergic interneurons requires both G protein-dependent and Src-ERK1/2-dependent signaling pathways, PLoS One, 9, e106316, 10.1371/journal.pone.0106316
Kufahl, 2012, Positive allosteric modulation of mGluR5 accelerates extinction learning but not relearning following methamphetamine self-administration, Front Pharmacol, 3, 194, 10.3389/fphar.2012.00194
Lavreysen, 2015, Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor, Pharmacol Res Perspect, 3, e00096, 10.1002/prp2.96
Lax, 2014, The mGluR5 antagonist fenobam induces analgesic conditioned place preference in mice with spared nerve injury, PLoS One, 9, e103524, 10.1371/journal.pone.0103524
Lebois, 2008, Neither typical nor atypical: LY404039 provides proof of concept that selective targeting of mGluR2/3 receptors is a valid mechanism for obtaining antipsychotic efficacy, Curr Top Med Chem, 8, 1480, 10.2174/156802608786264209
Lebourgeois, 2018, Pharmacological activation of mGlu4 and mGlu7 receptors, by LSP2-9166, reduces ethanol consumption and relapse in rat, Neuropharmacology, 133, 163, 10.1016/j.neuropharm.2018.01.031
Lee, 2016, The mGluR5 antagonist MPEP suppresses the expression and reinstatement, but not the acquisition, of the ethanol-conditioned place preference in mice, Pharmacol Biochem Behav, 140, 33, 10.1016/j.pbb.2015.10.015
Levitz, 2016, Mechanism of assembly and cooperativity of homomeric and heteromeric metabotropic glutamate receptors, Neuron, 92, 143, 10.1016/j.neuron.2016.08.036
Li, 2015, LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment, Exp Neurol, 273, 190, 10.1016/j.expneurol.2015.08.019
Li, 2016, Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats, Psychopharmacology (Berl), 233, 1801, 10.1007/s00213-016-4220-2
Li, 2010, Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2/3 mechanism in rats, J Neurochem, 114, 1368, 10.1111/j.1471-4159.2010.06851.x
Liberatore, 2017, Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration, Neuroscience, 363, 142, 10.1016/j.neuroscience.2017.09.005
Lindsley, 2016, Practical strategies and concepts in GPCR allosteric modulator discovery: recent advances with metabotropic glutamate receptors, Chem Rev, 116, 6707, 10.1021/acs.chemrev.5b00656
Litman, 2016, AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: a proof of principle study, Schizophr Res, 172, 152, 10.1016/j.schres.2016.02.001
Litschig, 1999, CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding, Mol Pharmacol, 55, 453
Lundström, 2016, Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2, Neuropharmacology, 111, 253, 10.1016/j.neuropharm.2016.08.032
Maj, 2016, The role of metabotropic glutamate receptor genes in schizophrenia, Curr Neuropharmacol, 14, 540, 10.2174/1570159X13666150514232745
Makoff, 1997, Expression of a novel splice variant of human mGluR1 in the cerebellum, Neuroreport, 8, 2943, 10.1097/00001756-199709080-00027
Malherbe, 1999, Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8, Brain Res Mol Brain Res, 67, 201, 10.1016/S0169-328X(99)00050-9
Mao, 2003, Metabotropic glutamate receptor 5-regulated Elk-1 phosphorylation and immediate early gene expression in striatal neurons, J Neurochem, 85, 1006, 10.1046/j.1471-4159.2003.01750.x
Marek, 2000, Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex, J Pharmacol Exp Ther, 292, 76
Matrisciano, 2008, Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis, Neuropharmacology, 54, 428, 10.1016/j.neuropharm.2007.10.020
Mazzitelli, 2018, Group II metabotropic glutamate receptors: role in pain mechanisms and pain modulation, Front Mol Neurosci, 11, 383, 10.3389/fnmol.2018.00383
McColm, 2017, Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects, Br J Clin Pharmacol, 83, 1654, 10.1111/bcp.13252
McCool, 1996, Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells, Mol Pharmacol, 50, 912
Megens, 2014, mGlu(2) receptor-mediated modulation of conditioned avoidance behavior in rats, Eur J Pharmacol, 727, 130, 10.1016/j.ejphar.2014.01.044
Metcalf, 2017, Efficacy of mGlu2 -positive allosteric modulators alone and in combination with levetiracetam in the mouse 6 Hz model of psychomotor seizures, Epilepsia, 58, 484, 10.1111/epi.13659
Minakami, 1995, The expression of two splice variants of metabotropic glutamate receptor subtype 5 in the rat brain and neuronal cells during development, J Neurochem, 65, 1536, 10.1046/j.1471-4159.1995.65041536.x
Miyashita, 2000, Extracellular Ca2+ sensitivity of mGluR1alpha associated with persistent glutamate response in transfected CHO cells, Receptors Channels, 7, 25
Miyashita, 2000, Extracellular Ca2+ sensitivity of mGluR1alpha induces an increase in the basal cAMP level by direct coupling with Gs protein in transfected CHO cells, Receptors Channels, 7, 77
Moloney, 2015, Negative allosteric modulation of the mGlu7 receptor reduces visceral hypersensitivity in a stress-sensitive rat strain, Neurobiol Stress, 2, 28, 10.1016/j.ynstr.2015.04.001
Monn, 2018, Synthesis and pharmacological characterization of C4β-amide-substituted 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 S,2 S,4 S,5 R,6 S)-2-amino-4-[(3-methoxybenzoyl)amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY2794193), a highly potent and selective mGlu3 receptor agonist, J Med Chem, 61, 2303, 10.1021/acs.jmedchem.7b01481
Monn, 2015, Synthesis and pharmacological characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY2812223), a highly potent, functionally selective mGlu2 receptor agonist, J Med Chem, 58, 7526, 10.1021/acs.jmedchem.5b01124
Montana, 2011, Metabotropic glutamate receptor 5 antagonism with fenobam: examination of analgesic tolerance and side effect profile in mice, Anesthesiology, 115, 1239, 10.1097/ALN.0b013e318238c051
Moreno Delgado, 2017, Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells, eLife, 6, e25233, 10.7554/eLife.25233
Moroni, 1997, Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist, J Pharmacol Exp Ther, 281, 721
Motolese, 2015, Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage, Mol Brain, 8, 66, 10.1186/s13041-015-0158-2
Murat, 2019, 5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling, Mol Psychiatry, 24, 1610, 10.1038/s41380-018-0069-6
Nadlewska, 2002, Effect of (S)-3,5-DHPG on learning, exploratory activity and anxiety in rats with experimental hypoxia, Pol J Pharmacol, 54, 11
Nakajima, 1993, Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate, J Biol Chem, 268, 11868, 10.1016/S0021-9258(19)50280-0
Namkoong, 2006, From existing therapies to novel targets: a current view on melanoma, Front Biosci, 11, 2081, 10.2741/1951
Nardecchia, 2018, Targeting mGlu5 metabotropic glutamate receptors in the treatment of cognitive dysfunction in a mouse model of phenylketonuria, Front Neurosci, 12, 154, 10.3389/fnins.2018.00154
Neto, 2018, Melanoma-associated GRM3 variants dysregulate melanosome trafficking and cAMP signaling, Pigment Cell Melanoma Res, 31, 115, 10.1111/pcmr.12610
Neugebauer, 1999, Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells, J Neurophysiol, 82, 272, 10.1152/jn.1999.82.1.272
Nicoletti, 2019, Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia, Front Psychiatry, 10, 49, 10.3389/fpsyt.2019.00049
O’Connor, 2013, The effects of mGlu7 receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains, Behav Pharmacol, 24, 105, 10.1097/FBP.0b013e32835efc78
Okamoto, 1994, Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction, J Biol Chem, 269, 1231, 10.1016/S0021-9258(17)42247-2
Olivero, 2017, Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate exocytosis in mouse cortex and spinal cord, Br J Pharmacol, 174, 4785, 10.1111/bph.14061
Palazzo, 2016, Metabotropic glutamate receptor 7: from synaptic function to therapeutic implications, Curr Neuropharmacol, 14, 504, 10.2174/1570159X13666150716165323
Palazzo, 2015, MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice, Pain, 156, 1060, 10.1097/j.pain.0000000000000150
Pałucha-Poniewiera, 2013, A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats, Behav Brain Res, 238, 109, 10.1016/j.bbr.2012.10.004
Panaccione, 2017, Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus, Pharmacol Res, 117, 46, 10.1016/j.phrs.2016.11.029
Pandya, 2016, Group 1 metabotropic glutamate receptors 1 and 5 form a protein complex in mouse hippocampus and cortex, Proteomics, 16, 2698, 10.1002/pmic.201500400
Park, 2019, Activation of peripheral group III metabotropic glutamate receptors inhibits pain transmission by decreasing neuronal excitability in the CFA-inflamed knee joint, Neurosci Lett, 694, 111, 10.1016/j.neulet.2018.11.033
Perez-Benito, 2017, Molecular switches of allosteric modulation of the metabotropic glutamate 2 receptor, Structure, 25, 1153, 10.1016/j.str.2017.05.021
Perez-Garcia, 2018, PTSD-related behavioral traits in a rat model of blast-induced mTBI are reversed by the mGluR2/3 receptor antagonist BCI-838, eNeuro, 5, ENEURO.0357, 10.1523/ENEURO.0357-17.2018
Peterlik, 2017, Blocking metabotropic glutamate receptor subtype 5 relieves maladaptive chronic stress consequences, Brain Behav Immun, 59, 79, 10.1016/j.bbi.2016.08.007
Pietraszek, 2004, Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine, J Physiol Pharmacol, 55, 587
Pitsikas, 2012, The metabotropic glutamate 2/3 receptor antagonist LY341495 differentially affects recognition memory in rats, Behav Brain Res, 230, 374, 10.1016/j.bbr.2012.02.027
Podkowa, 2018, The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice, Neuropharmacology, 141, 214, 10.1016/j.neuropharm.2018.08.022
Podkowa, 2016, Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats, Psychopharmacology (Berl), 233, 2901, 10.1007/s00213-016-4325-7
Podkowa, 2015, A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action, Neuropharmacology, 97, 338, 10.1016/j.neuropharm.2015.05.039
Ponnazhagan, 2016, The metabotropic glutamate receptor 4 positive allosteric modulator ADX88178 inhibits inflammatory responses in primary microglia, J Neuroimmune Pharmacol, 11, 231, 10.1007/s11481-016-9655-z
Poutiainen, 2015, Co-operative binding assay for the characterization of mGlu4 allosteric modulators, Neuropharmacology, 97, 142, 10.1016/j.neuropharm.2015.05.017
Quiroz, 2016, Efficacy and safety of basimglurant as adjunctive therapy for major depression: a randomized clinical trial, JAMA Psychiatry, 73, 675, 10.1001/jamapsychiatry.2016.0838
Rahman, 1996, Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones, Br J Pharmacol, 117, 675, 10.1111/j.1476-5381.1996.tb15243.x
Ritter-Makinson, 2017, Group II metabotropic glutamate receptor interactions with NHERF scaffold proteins: implications for receptor localization in brain, Neuroscience, 353, 58, 10.1016/j.neuroscience.2017.03.060
Roche, 2014, Mathematical modeling of G protein-coupled receptor function: what can we learn from empirical and mechanistic models?, Adv Exp Med Biol, 796, 159, 10.1007/978-94-007-7423-0_8
Rodriguez, 2005, A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators, Mol Pharmacol, 68, 1793, 10.1124/mol.105.016139
Rouzade-Dominguez ML Pezous N David OJ Tutuian R Bruley des Varannes S Tack J Malfertheiner P Allescher HD Ufer M Rühl A (2017) The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease. Neurogastroenterol Motil 29 Available from: 10.1111/nmo.13058.
Rovira, 2016, OptoGluNAM4.1, a photoswitchable allosteric antagonist for real-time control of mGlu4 aeceptor activity, Cell Chem Biol, 23, 929, 10.1016/j.chembiol.2016.06.013
Rutrick, 2017, Mavoglurant augmentation in OCD patients resistant to selective serotonin reuptake inhibitors: a proof-of-concept, randomized, placebo-controlled, phase 2 study, Adv Ther, 34, 524, 10.1007/s12325-016-0468-5
Saini, 2017, Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk, Transl Psychiatry, 7, e1196, 10.1038/tp.2017.172
Saugstad, 1994, Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors, Mol Pharmacol, 45, 367
Schoepp, 2001, Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system, J Pharmacol Exp Ther, 299, 12
Schröder, 2008, The potent non-competitive mGlu1 receptor antagonist BAY 36-7620 differentially affects synaptic plasticity in area cornu ammonis 1 of rat hippocampal slices and impairs acquisition in the water maze task in mice, Neuroscience, 157, 385, 10.1016/j.neuroscience.2008.08.063
Sebastianutto, 2020, D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease, J Clin Invest, 130, 1168, 10.1172/JCI126361
Sekiyama, 1996, Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes, Br J Pharmacol, 117, 1493, 10.1111/j.1476-5381.1996.tb15312.x
Selvam, 2018, Increased potency and selectivity for group III metabotropic glutamate receptor agonists binding at dual sites, J Med Chem, 61, 1969, 10.1021/acs.jmedchem.7b01438
Sengmany, 2019, Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology, Neuropharmacology, 149, 83, 10.1016/j.neuropharm.2019.02.005
Sengmany, 2017, Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: implications for optimizing preclinical neuroscience drug discovery, Neuropharmacology, 115, 60, 10.1016/j.neuropharm.2016.07.001
Sengmany, 2020, Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism, Biochem Pharmacol, 177, 114011, 10.1016/j.bcp.2020.114011
Shah, 2019, Serotonin and glutamate interactions in preclinical schizophrenia models, ACS Chem Neurosci, 10, 3068, 10.1021/acschemneuro.9b00044
Shannon, 2005, Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist, Neuropharmacology, 49, 188, 10.1016/j.neuropharm.2005.05.010
Silverstein, 1986, The glutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain, Neurosci Lett, 71, 13, 10.1016/0304-3940(86)90249-1
Soloviev, 1999, Identification, cloning and analysis of expression of a new alternatively spliced form of the metabotropic glutamate receptor mGluR1 mRNA1, Biochim Biophys Acta, 1446, 161, 10.1016/S0167-4781(99)00083-4
Spampinato, 2018, Metabotropic glutamate receptors in glial cells: a new potential target for neuroprotection?, Front Mol Neurosci, 11, 414, 10.3389/fnmol.2018.00414
Stachowicz, 2006, Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling, Pharmacol Rep, 58, 820
Szczurowska, 2012, Positive allosteric modulator of mGluR4 PHCCC exhibits proconvulsant action in three models of epileptic seizures in immature rats, Physiol Res, 61, 619, 10.33549/physiolres.932336
Tassin, 2016, Phasic and Tonic mGlu7 receptor activity modulates the thalamocortical network, Front Neural Circuits, 10, 31, 10.3389/fncir.2016.00031
Tateyama, 2008, Regulatory role of C-terminus in the G-protein coupling of the metabotropic glutamate receptor 1, J Neurochem, 107, 1036, 10.1111/j.1471-4159.2008.05672.x
Techlovská, 2014, Metabotropic glutamate receptor 1 splice variants mGluR1a and mGluR1b combine in mGluR1a/b dimers in vivo, Neuropharmacology, 86, 329, 10.1016/j.neuropharm.2014.08.011
Thomsen, 1993, Serine-O-phosphate has affinity for type IV, but not type I, metabotropic glutamate receptor, Neuroreport, 4, 1099
Tomita, 2000, The effects of DCG-IV and L-CCG-1 upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice, Ann N Y Acad Sci, 914, 284, 10.1111/j.1749-6632.2000.tb05203.x
Tora, 2018, Chloride ions stabilize the glutamate-induced active state of the metabotropic glutamate receptor 3, Neuropharmacology, 140, 275, 10.1016/j.neuropharm.2018.08.011
Trenkwalder, 2016, Mavoglurant in Parkinson’s patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studies, Mov Disord, 31, 1054, 10.1002/mds.26585
Tresadern, 2017, Identification of allosteric modulators of metabotropic glutamate 7 receptor using proteochemometric modeling, J Chem Inf Model, 57, 2976, 10.1021/acs.jcim.7b00338
Varnäs, 2020, The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans, Neuropharmacology, 162, 107809, 10.1016/j.neuropharm.2019.107809
Vergouts, 2017, PKC epsilon-dependent calcium oscillations associated with metabotropic glutamate receptor 5 prevent agonist-mediated receptor desensitization in astrocytes, J Neurochem, 141, 387, 10.1111/jnc.14007
Volpi, 2018, Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4, Expert Opin Drug Discov, 13, 411, 10.1080/17460441.2018.1443076
Volpi, 2016, Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells, Neuropharmacology, 102, 59, 10.1016/j.neuropharm.2015.10.036
Wagner, 2015, Homer1/mGluR5 activity moderates vulnerability to chronic social stress, Neuropsychopharmacology, 40, 1222, 10.1038/npp.2014.308
Wenthur, 2014, Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs, Bioorg Med Chem Lett, 24, 2693, 10.1016/j.bmcl.2014.04.051
Woltering, 2008, Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists, Bioorg Med Chem Lett, 18, 2725, 10.1016/j.bmcl.2008.02.076
Woźniak, 2017, Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022, Neuropharmacology, 115, 149, 10.1016/j.neuropharm.2016.06.025
Xiang, 2019, mGlu5 Positive allosteric modulators facilitate long-term potentiation via disinhibition mediated by mGlu5-endocannabinoid signaling, ACS Pharmacol Transl Sci, 2, 198, 10.1021/acsptsci.9b00017
Xing, 2018, Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β, Neuropharmacology, 137, 359, 10.1016/j.neuropharm.2018.05.019
Yohn SE Foster DJ Covey DP Moehle MS Galbraith J Garcia-Barrantes PM Cho HP Bubser M Blobaum AL Joffe ME (2018) Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators. Mol Psychiatry DOI: 10.1038/s41380-018-0206-2 [published ahead of print].
Zalewska, 1997, Behavioral activity of 1S,3R-ACPD, an agonist of metabotropic glutamate receptors, Pol J Pharmacol, 49, 239
Zalewska-Wińska, 2000, Behavioural activity of (S)-3,5-DHPG, a selective agonist of group I metabotropic glutamate receptors, Pharmacol Res, 42, 239, 10.1006/phrs.2000.0683
Zeleznikow-Johnston, 2018, Touchscreen testing reveals clinically relevant cognitive abnormalities in a mouse model of schizophrenia lacking metabotropic glutamate receptor 5, Sci Rep, 8, 16412, 10.1038/s41598-018-33929-3
Zhang, 2019, Activation of type 4 metabotropic glutamate receptor promotes cell apoptosis and inhibits proliferation in bladder cancer, J Cell Physiol, 234, 2741, 10.1002/jcp.27089
Zhang, 2015, Activation of mGluR5 attenuates microglial activation and neuronal apoptosis in early brain injury after experimental subarachnoid hemorrhage in rats, Neurochem Res, 40, 1121, 10.1007/s11064-015-1572-7
Zolkowska, 2016, Influence of MPEP (a selective mGluR5 antagonist) on the anticonvulsant action of novel antiepileptic drugs against maximal electroshock-induced seizures in mice, Prog Neuropsychopharmacol Biol Psychiatry, 65, 172, 10.1016/j.pnpbp.2015.10.005
Zuena, 2018, In vivo non-radioactive assessment of mGlu5 receptor-activated polyphosphoinositide hydrolysis in response to systemic administration of a positive allosteric modulator, Front Pharmacol, 9, 804, 10.3389/fphar.2018.00804